2008
DOI: 10.1016/j.brainres.2008.06.025
|View full text |Cite
|
Sign up to set email alerts
|

Distribution of the monocarboxylate transporter MCT2 in human cerebral cortex: An immunohistochemical study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
20
1

Year Published

2012
2012
2022
2022

Publication Types

Select...
8
1
1

Relationship

2
8

Authors

Journals

citations
Cited by 26 publications
(21 citation statements)
references
References 36 publications
0
20
1
Order By: Relevance
“…MCT2 is the main monocarboxylate transporter isoform present on neurons [20,30,40]. In MCT2 rats, no rise in lactate content was observed during whisker stimulation.…”
Section: Discussionmentioning
confidence: 99%
“…MCT2 is the main monocarboxylate transporter isoform present on neurons [20,30,40]. In MCT2 rats, no rise in lactate content was observed during whisker stimulation.…”
Section: Discussionmentioning
confidence: 99%
“…52,53 MCT3 has an intermediate affinity (Km 6 mmol/L) 54 and is predominantly expressed in retinal epithelial cells and in the choroid plexus epithelial cells (which are developmentally homologous to the latter), but not in the ependymal cells lining the cerebral ventricles. 17 The high-affinity transporter MCT2 is abundantly detected on neurons and astrocytes by immunohistochemical methods, 55 but shows substantial species differences in distribution. In rat brain, MCT2 immunoreactivity has primarily been found on perivascular endfeet 8,9,56 and postsynaptic densities.…”
Section: Monocarboxylate Transportersmentioning
confidence: 99%
“…Although 14 isoforms of MCTs have been identified by in silico analysis of the human genome (known as the SLC16A membrane transporter family), only 4 (MCTs 1-4) are known to be involved in lactic acid transport in normal and tumor tissue [17], [18], [19]. We [10] and others [20], [21], [22], [23] have previously demonstrated differential expression of MCT isoforms in brain tumors versus normal brain. In vitro and in vivo studies by us and others have used RNA interference and α-cyano-4-hydroxycinnamic acid (ACCA, CHC), a small-molecule inhibitor against MCTs, to target tumor expressed MCT isoforms and selectively interfere with lactate efflux by glioma [8], [10], [11], [23].…”
Section: Introductionmentioning
confidence: 99%